4-Androstenedione API - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > 4-Androstenedione API - Global Top Players Market Share and Ranking 2025

4-Androstenedione API - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-12-09
Report Id: 2861284
Industry: Pharma & Healthcare
Report Page: 99
Chart: 95

PDF Download

Publication Date: 2025-12-09
Report Id: 2861284
Industry: Pharma & Healthcare
Report Page: 99
Chart: 95

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 4-Androstenedione API Definition
1.2 Global 4-Androstenedione API Market Size and Forecast
1.2.1 By Consumption Value, Global 4-Androstenedione API Market Size, 2020-2031
1.2.2 By Sales Quantity, Global 4-Androstenedione API Market Size, 2020-2031
1.2.3 Global 4-Androstenedione API Average Selling Price (ASP), 2020-2031
1.3 China 4-Androstenedione API Market Size and Forecast
1.3.1 By Consumption Value, China 4-Androstenedione API Market Size, 2020-2031
1.3.2 By Sales Quantity, China 4-Androstenedione API Market Size, 2020-2031
1.3.3 China 4-Androstenedione API Average Selling Price (ASP), 2020-2031
1.4 Share of China 4-Androstenedione API Market with Respect to the Global Market
1.4.1 By Consumption Value, China 4-Androstenedione API Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China 4-Androstenedione API Market Share in Global, 2020-2031
1.4.3 4-Androstenedione API Market Size: China VS Global, 2020-2031
1.5 4-Androstenedione API Market Dynamics
1.5.1 4-Androstenedione API Market Drivers
1.5.2 4-Androstenedione API Market Restraints
1.5.3 4-Androstenedione API Industry Trends
1.5.4 4-Androstenedione API Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of 4-Androstenedione API, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of 4-Androstenedione API, Global Market Share by Company, 2020-2025
2.3 4-Androstenedione API Average Selling Price (ASP) by Company, 2020-2025
2.4 Global 4-Androstenedione API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global 4-Androstenedione API Concentration Ratio
2.6 Global 4-Androstenedione API Mergers & Acquisitions, Expansion Plans
2.7 Global 4-Androstenedione API Manufacturers Product Type
2.8 Head Office and 4-Androstenedione API Production Site of Key Manufacturer
2.9 4-Androstenedione API Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of 4-Androstenedione API, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of 4-Androstenedione API, China Market Share by Company, 2020-2025
3.3 China 4-Androstenedione API 4-Androstenedione API Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global 4-Androstenedione API Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global 4-Androstenedione API Capacity by Region
4.3 Global 4-Androstenedione API Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global 4-Androstenedione API Production by Region, 2020-2031
4.5 Global 4-Androstenedione API Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 4-Androstenedione API Industry Chain
5.2 4-Androstenedione API Upstream Analysis
5.2.1 4-Androstenedione API Core Raw Materials
5.2.2 Main Manufacturers of 4-Androstenedione API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 4-Androstenedione API Production Mode
5.6 4-Androstenedione API Procurement Model
5.7 4-Androstenedione API Industry Sales Model and Sales Channels
5.7.1 4-Androstenedione API Sales Model
5.7.2 4-Androstenedione API Typical Distributors

6 Sights by Type
6.1 4-Androstenedione API Classification by Type
6.1.1 Content <99%
6.1.2 Content ≥99%
6.2 by Type, Global 4-Androstenedione API Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global 4-Androstenedione API Consumption Value, 2020-2031
6.4 by Type, Global 4-Androstenedione API Sales Quantity, 2020-2031
6.5 by Type, Global 4-Androstenedione API Average Selling Price (ASP), 2020-2031

7 Sights by Terminal Formulation
7.1 4-Androstenedione API Classification by Terminal Formulation
7.1.1 Oral Preparations
7.1.2 Injectable Preparations
7.1.3 Topical Preparations
7.2 by Terminal Formulation, Global 4-Androstenedione API Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Terminal Formulation, Global 4-Androstenedione API Consumption Value, 2020-2031
7.4 by Terminal Formulation, Global 4-Androstenedione API Sales Quantity, 2020-2031
7.5 by Terminal Formulation, Global 4-Androstenedione API Average Selling Price (ASP), 2020-2031

8 Sights by Synthesis Process
8.1 4-Androstenedione API Classification by Synthesis Process
8.1.1 Chemical Synthesis
8.1.2 Biotransformation
8.2 by Synthesis Process, Global 4-Androstenedione API Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Synthesis Process, Global 4-Androstenedione API Consumption Value, 2020-2031
8.4 by Synthesis Process, Global 4-Androstenedione API Sales Quantity, 2020-2031
8.5 by Synthesis Process, Global 4-Androstenedione API Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 4-Androstenedione API Segment by Application
9.1.1 Corticosteroids
9.1.2 Progesterone
9.1.3 Sex hormones
9.2 by Application, Global 4-Androstenedione API Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global 4-Androstenedione API Consumption Value, 2020-2031
9.4 by Application, Global 4-Androstenedione API Sales Quantity, 2020-2031
9.5 by Application, Global 4-Androstenedione API Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global 4-Androstenedione API Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global 4-Androstenedione API Consumption Value, 2020-2031
10.3 By Region, Global 4-Androstenedione API Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America 4-Androstenedione API Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America 4-Androstenedione API Market Size Market Share
10.5 Europe
10.5.1 Europe 4-Androstenedione API Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe 4-Androstenedione API Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific 4-Androstenedione API Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific 4-Androstenedione API Market Size Market Share
10.7 South America
10.7.1 South America 4-Androstenedione API Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America 4-Androstenedione API Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global 4-Androstenedione API Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global 4-Androstenedione API Consumption Value, 2020-2031
11.3 By Country, Global 4-Androstenedione API Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States 4-Androstenedione API Market Size, 2020-2031
11.4.2 by Type, United States 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe 4-Androstenedione API Market Size, 2020-2031
11.5.2 by Type, Europe 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China 4-Androstenedione API Market Size, 2020-2031
11.6.2 by Type, China 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan 4-Androstenedione API Market Size, 2020-2031
11.7.2 by Type, Japan 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea 4-Androstenedione API Market Size, 2020-2031
11.8.2 by Type, South Korea 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia 4-Androstenedione API Market Size, 2020-2031
11.9.2 by Type, Southeast Asia 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India 4-Androstenedione API Market Size, 2020-2031
11.10.2 by Type, India 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa 4-Androstenedione API Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa 4-Androstenedione API Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Saituo Biological Technology
12.1.1 Saituo Biological Technology Company Information, Head Office, Market Area, and Industry Position
12.1.2 Saituo Biological Technology 4-Androstenedione API Models, Specifications, and Application
12.1.3 Saituo Biological Technology 4-Androstenedione API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Saituo Biological Technology Company Profile and Main Business
12.1.5 Saituo Biological Technology Recent Developments
12.2 Hubei Goto Biopharm
12.2.1 Hubei Goto Biopharm Company Information, Head Office, Market Area, and Industry Position
12.2.2 Hubei Goto Biopharm 4-Androstenedione API Models, Specifications, and Application
12.2.3 Hubei Goto Biopharm 4-Androstenedione API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Hubei Goto Biopharm Company Profile and Main Business
12.2.5 Hubei Goto Biopharm Recent Developments
12.3 Bayer
12.3.1 Bayer Company Information, Head Office, Market Area, and Industry Position
12.3.2 Bayer 4-Androstenedione API Models, Specifications, and Application
12.3.3 Bayer 4-Androstenedione API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Bayer Company Profile and Main Business
12.3.5 Bayer Recent Developments
12.4 Rifa Pharma
12.4.1 Rifa Pharma Company Information, Head Office, Market Area, and Industry Position
12.4.2 Rifa Pharma 4-Androstenedione API Models, Specifications, and Application
12.4.3 Rifa Pharma 4-Androstenedione API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Rifa Pharma Company Profile and Main Business
12.4.5 Rifa Pharma Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for 4-Androstenedione API should grow from US$ 66.99 million in 2024 to US$ 82.00 million by 2031, with a CAGR of 2.6% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

4-Androstenedione API

According to YH Research, the global market for 4-Androstenedione API should grow from US$ 66.99 million in 2024 to US$ 82.00 million by 2031, with a CAGR of 2.6% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

4-androstenedione, or androstenedione (abbreviated as A4 or Δ4-dione), also known as androst-4-ene-3,17-dione, is an endogenous weak androgen steroid hormone and intermediate in the biosynthesis of estrone and of testosterone from dehydroepiandrosterone (DHEA).

In 2024, global production of 4-androstenedione reached 1,457 tons, with an average selling price of US$43.5/kg and a production capacity of approximately 3,000 tons. The industry's gross profit margin was approximately 10%–20%. Cost structure: Direct materials accounted for approximately 70%, manufacturing costs for approximately 23%, and labor costs for approximately 7%. Industry chain: Upstream main raw materials include phytosterols and soybean oil fatty acids, while downstream products are steroidal drug raw materials, including corticosteroids, progestins, and sex hormones.

The global market for 4-Androstenedione API is experiencing steady growth, driven primarily by its essential role as a key intermediate in the synthesis of various steroid hormones and pharmaceuticals. The production landscape is relatively concentrated, with major players like Tianjin Jin Yao Group, BIOVET, and Indo Phyto Chemicals dominating the market share. A significant portion of global manufacturing is situated in the Asia-Pacific region, particularly in China. This growth, however, is tempered by several challenges. The market faces headwinds from evolving international trade policies and rising tariff barriers, which complicate supply chains and increase export costs for producers. Furthermore, the industry must continuously adapt to stringent and increasingly rigorous environmental regulations and quality compliance standards across different regions. The future trajectory of the market will likely be determined by how effectively manufacturers navigate these regulatory complexities while pursuing technological advancements and operational efficiency.

This report studies and analyses global 4-Androstenedione API status and future trends, helps the client to determine the 4-Androstenedione API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for 4-Androstenedione API, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global 4-Androstenedione API market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Tons)
(2) Global 4-Androstenedione API sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(3) China 4-Androstenedione API sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Tons)
(4) Global 4-Androstenedione API key consuming regions, consumption quantity, consumption value and demand structure
(5) Global 4-Androstenedione API key producing regions, capacity, production, and year over year growth
(6) 4-Androstenedione API industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Saituo Biological Technology
    Hubei Goto Biopharm
    Bayer
    Rifa Pharma

Market segment by Type, covers
    Content <99%
    Content ≥99%

Market segment by Terminal Formulation, covers
    Oral Preparations
    Injectable Preparations
    Topical Preparations

Market segment by Synthesis Process, covers
    Chemical Synthesis
    Biotransformation

Market segment by Application, can be divided into
    Corticosteroids
    Progesterone
    Sex hormones

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe 4-Androstenedione API product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global 4-Androstenedione API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China 4-Androstenedione API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of 4-Androstenedione API, percent & CAGR, 2020-2031
Chapter 5: 4-Androstenedione API industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.